Personalized management of pheochromocytoma and paraganglioma
S Nölting, N Bechmann, D Taieb… - Endocrine …, 2022 - academic.oup.com
Pheochromocytomas/paragangliomas are characterized by a unique molecular landscape
that allows their assignment to clusters based on underlying genetic alterations. With around …
that allows their assignment to clusters based on underlying genetic alterations. With around …
An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma
A Buffet, N Burnichon, J Favier… - Best practice & research …, 2020 - Elsevier
Paragangliomas and pheochromocytomas (PPGL) are rare neuroendocrine tumours
characterized by a strong genetic determinism. Over the past 20 years, evolution of PPGL …
characterized by a strong genetic determinism. Over the past 20 years, evolution of PPGL …
Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas
R García-Carbonero, F Matute Teresa… - Clinical and …, 2021 - Springer
Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors that
arise from chromaffin cells of the adrenal medulla and the sympathetic/parasympathetic …
arise from chromaffin cells of the adrenal medulla and the sympathetic/parasympathetic …
The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and management of metastatic and/or unresectable pheochromocytoma …
L Fishbein, J Del Rivero, T Else, JR Howe, SL Asa… - Pancreas, 2021 - journals.lww.com
This manuscript is the result of the North American Neuroendocrine Tumor Society
consensus conference on the medical management and surveillance of metastatic and …
consensus conference on the medical management and surveillance of metastatic and …
Metastatic pheochromocytomas and abdominal paragangliomas
D Granberg, CC Juhlin… - The journal of clinical …, 2021 - academic.oup.com
Abstract Context Pheochromocytomas and paragangliomas (PPGLs) are believed to harbor
malignant potential; about 10% to 15% of pheochromocytomas and up to 50% of abdominal …
malignant potential; about 10% to 15% of pheochromocytomas and up to 50% of abdominal …
New insights on the genetics of pheochromocytoma and paraganglioma and its clinical implications
Simple Summary Pheochromocytoma and paraganglioma (together PPGL) are rare
neuroendocrine tumors that arise from chromaffin tissue and produce catecholamines …
neuroendocrine tumors that arise from chromaffin tissue and produce catecholamines …
Genetic bases of pheochromocytoma and paraganglioma
The genetics of pheochromocytoma and paraganglioma (PPGL) has become increasingly
complex over the last two decades. The list of genes involved in the development of these …
complex over the last two decades. The list of genes involved in the development of these …
Pheochromocytoma: a changing perspective and current concepts
A Kiriakopoulos, P Giannakis… - … in endocrinology and …, 2023 - journals.sagepub.com
This article aims to review current concepts in diagnosing and managing
pheochromocytoma and paraganglioma (PPGL). Personalized genetic testing is vital, as 40 …
pheochromocytoma and paraganglioma (PPGL). Personalized genetic testing is vital, as 40 …
Metabolic enzyme DLST promotes tumor aggression and reveals a vulnerability to OXPHOS inhibition in high-risk neuroblastoma
High-risk neuroblastoma remains therapeutically challenging to treat, and the mechanisms
promoting disease aggression are poorly understood. Here, we show that elevated …
promoting disease aggression are poorly understood. Here, we show that elevated …
Ovarian cancer modulates the immunosuppressive function of CD11b+ Gr1+ myeloid cells via glutamine metabolism
Abstract Objective Immature CD11b+ Gr1+ myeloid cells that acquire immunosuppressive
capability, also known as myeloid-derived suppressor cells (MDSCs), are a heterogeneous …
capability, also known as myeloid-derived suppressor cells (MDSCs), are a heterogeneous …